ISSN: 1934-662X

Journal Home

Journal Guideline

Cancer Cytopathology Q1 Unclaimed

Wiley-Blackwell United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Cytopathology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 64. It has a price of 2100 €. It has an SJR impact factor of 1,231 and it has a best quartile of Q1. It has an SJR impact factor of 1,231.

Cancer Cytopathology focuses its scope in these topics and keywords: methods, cytology, liquidbased, dual, human, women, conventional, unsatisfactory, papanicolaou, pinkaki, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q1) Cancer Research (Q2)

Price

2100 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,231

SJR Impact factor

64

H Index

129

Total Docs (Last Year)

365

Total Docs (3 years)

3521

Total Refs

1028

Total Cites (3 years)

238

Citable Docs (3 years)

2.77

Cites/Doc (2 years)

27.29

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Molecular Cancer Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis

Thyroid FNA: Is cytopathologist review of ultrasound features useful?

Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (>1.0 cm) that were not targeted

Thyroid FNA: New classifications and new interpretations

The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the quality of reporting, "risk" of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions

The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio

Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors

Synovial sarcoma: Diagnosis on fine-needle aspiration by morphology and molecular analysis

Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution

Rapid on-site evaluation for endoscopic ultrasound-guided fine-needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures

The diagnostic utility of next-generation sequencing on FNA biopsies of melanocytic uveal lesions

Molecular testing of cytology specimens: Are we ready for the new era?

SHOW MORE ARTICLES

Fine-needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocytosis

The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System

Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?

Application of a machine learning algorithm to predict malignancy in thyroid cytopathology

Toward a multimodal cell analysis of brush biopsies for the early detection of oral cancer

Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma

The role of systematic review and meta-analysis in modern cytopathology

Is the cytodiagnosis of mesothelioma any easier these days?

Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity

Color blindness in the medical workplace

Cytologic and molecular diagnosis of thyroid cancers

Cervical and anal cancer prevention in jails and prisons: "A missed opportunity"